Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

[1]  Zi Ye,et al.  Survival in patients with poorly compressible leg arteries. , 2012, Journal of the American College of Cardiology.

[2]  John V. White,et al.  2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) , 2011, Vascular medicine.

[3]  John V. White,et al.  2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.

[4]  F. Soria,et al.  Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. , 2011, International journal of cardiology.

[5]  M. Rutter,et al.  The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial , 2011, Diabetes Care.

[6]  C. Suárez,et al.  Different prognostic value of silent peripheral artery disease in type 2 diabetic and non-diabetic subjects with stable cardiovascular disease. , 2011, Atherosclerosis.

[7]  Deepak L. Bhatt,et al.  Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. , 2010, JAMA.

[8]  Ronald J. Prineas,et al.  The Minnesota Code Manual of Electrocardiographic Findings , 2009 .

[9]  Maria Mori Brooks,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[10]  Sheng-Chia Chung,et al.  Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial , 2008 .

[11]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[12]  A. Newman,et al.  Relationship of Ankle Blood Pressures to Cardiovascular Events in Older Adults , 2008, Stroke.

[13]  R. Frye,et al.  Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. , 2006, The American journal of cardiology.

[14]  P. Norman,et al.  Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. , 2006, Diabetes Care.

[15]  A. Newman,et al.  Mortality and Cardiovascular Risk Across the Ankle-Arm Index Spectrum: Results From the Cardiovascular Health Study , 2006, Circulation.

[16]  Richard B Devereux,et al.  Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.

[17]  Akira Maezawa,et al.  Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. , 2003, Journal of the American Society of Nephrology : JASN.

[18]  D. Smith,et al.  Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. , 1999, Diabetes care.

[19]  R. Stout,et al.  Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. , 1991, The American journal of medicine.

[20]  A. Cerami,et al.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.